Riskpilot← Back to searchSign inGet full accessMedimare Oy
OYDissolvedY-tunnus 2925873-4A A 1Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
EUR 47K
+9% vs 2024
EBITDA margin
36.5%
+551% vs 2024
Equity ratio
84.3%
Financial strength
Net profit 2025
EUR 14K
-94% vs 2024
| Revenue | EUR 47K | +9% |
| EBITDA | EUR 17K | +551% |
| Net profit | EUR 14K | -94% |
| Total assets | EUR 27K | -97% |
| Equity | EUR 23K | -97% |
| Employees | 1 | — |
Legal name
Medimare Oy
Y-tunnus number
2925873-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
6. heinäkuuta 2018
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on erikoislääkärin palvelut, niihin liittyvä koulutus ja konsultointi sekä kaikki laillinen liiketoiminta.
Address
A A 1
Email
maanri@utu.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 68 | 67 | 64 | 43 | 47 |
| Staff expenses | −42 | −37 | −48 | −39 | −20 |
| EBITDA | 8 | 12 | −6 | 3 | 17 |
| Depreciation & amort. | −4 | −3 | −2 | −0 | −0 |
| EBIT | 4 | 9 | −8 | 261 | 17 |
| Net financials | −0 | −0 | −0 | −0 | 0 |
| Profit before tax | 4 | 9 | −8 | 3 | 17 |
| Tax | 1 | 2 | −0 | −0 | 3 |
| Net profit | 3 | 7 | −8 | 260 | 14 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 | 18 | 10 | 904 | 27 |
| Equity | 10 | 15 | 6 | 857 | 23 |
| Long-term debt | — | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 3 | 4 | 47 | 4 |
| Total debt | 5 | 3 | 4 | 0 | 4 |
EBITDA margin
36.5%
This company
15.8%
Market median
+131% vs market
20212025
Equity ratio
84.3%
This company
38.2%
Market median
+121% vs market
20212025
Return on equity
62.8%
This company
18.4%
Market median
+241% vs market
20212025
Net profit margin
31.0%
This company
8.1%
Market median
+283% vs market
20212025
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ Deputy Member | Deputy Member | 2018 |
VJ Deputy Member | Deputy Member | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medimare Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Santeri Jaakko Joonatan Rintala | Deputy Member | 0 companies |
| Valtteri Jaakko Hermanni Rintala | Deputy Member | 0 companies |
| Marjut Anne Mirjam Haataja | Board of Directors | 0 companies |